Fidson Healthcare Plc (NGX:FIDSON)

Nigeria flag Nigeria · Delayed Price · Currency is NGN
48.00
+3.50 (7.87%)
At close: Dec 30, 2025
220.00%
Market Cap102.13B
Revenue (ttm)117.54B
Net Income (ttm)10.31B
Shares Out2.29B
EPS (ttm)4.49
PE Ratio9.92
Forward PE9.65
Dividend1.00 (2.25%)
Ex-Dividend DateJul 14, 2025
Volume8,587,699
Average Volume828,444
Open46.90
Previous Close44.50
Day's Range46.90 - 48.00
52-Week Range14.79 - 48.00
Beta0.53
RSI96.42
Earnings DateMar 27, 2026

About Fidson Healthcare

Fidson Healthcare Plc manufactures and distributes pharmaceutical products in Nigeria. The company operates in three segments: Over-the-Counter, Ethical Products, and Consumer Healthcare Product. It offers drugs, infusions, and injectables. The company also provides products for anti infective and anti malaria, central nervous system, and cough and cold, gastrointestinal medicines; supplements; topical/dermatological medicines; vitamins and minerals; and ophthalmic solutions. Fidson Healthcare Plc was incorporated in 1995 and is headquartered i... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 674
Stock Exchange Nigerian Stock Exchange
Ticker Symbol FIDSON
Full Company Profile

Financial Performance

In 2024, Fidson Healthcare's revenue was 84.19 billion, an increase of 58.70% compared to the previous year's 53.05 billion. Earnings were 5.78 billion, an increase of 60.20%.

Financial Statements

News

There is no news available yet.